JP2009522244A5 - - Google Patents

Download PDF

Info

Publication number
JP2009522244A5
JP2009522244A5 JP2008548029A JP2008548029A JP2009522244A5 JP 2009522244 A5 JP2009522244 A5 JP 2009522244A5 JP 2008548029 A JP2008548029 A JP 2008548029A JP 2008548029 A JP2008548029 A JP 2008548029A JP 2009522244 A5 JP2009522244 A5 JP 2009522244A5
Authority
JP
Japan
Prior art keywords
compound
aziridin
hydroxylamino
nitrobenzamide
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008548029A
Other languages
English (en)
Japanese (ja)
Other versions
JP5368803B2 (ja
JP2009522244A (ja
Filing date
Publication date
Priority claimed from GB0526552A external-priority patent/GB0526552D0/en
Application filed filed Critical
Publication of JP2009522244A publication Critical patent/JP2009522244A/ja
Publication of JP2009522244A5 publication Critical patent/JP2009522244A5/ja
Application granted granted Critical
Publication of JP5368803B2 publication Critical patent/JP5368803B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008548029A 2005-12-29 2006-12-29 α−ヒドロキシカルボニル化合物の還元剤としての使用 Active JP5368803B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0526552A GB0526552D0 (en) 2005-12-29 2005-12-29 New use
GB0526552.5 2005-12-29
PCT/GB2006/004947 WO2007074344A1 (en) 2005-12-29 2006-12-29 Use of alpha-hydroxy carbonyl compounds as reducing agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013015431A Division JP5699170B2 (ja) 2005-12-29 2013-01-30 α−ヒドロキシカルボニル化合物の還元剤としての使用

Publications (3)

Publication Number Publication Date
JP2009522244A JP2009522244A (ja) 2009-06-11
JP2009522244A5 true JP2009522244A5 (cg-RX-API-DMAC7.html) 2010-02-18
JP5368803B2 JP5368803B2 (ja) 2013-12-18

Family

ID=35841324

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008548029A Active JP5368803B2 (ja) 2005-12-29 2006-12-29 α−ヒドロキシカルボニル化合物の還元剤としての使用
JP2013015431A Active JP5699170B2 (ja) 2005-12-29 2013-01-30 α−ヒドロキシカルボニル化合物の還元剤としての使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013015431A Active JP5699170B2 (ja) 2005-12-29 2013-01-30 α−ヒドロキシカルボニル化合物の還元剤としての使用

Country Status (15)

Country Link
US (3) US9029569B2 (cg-RX-API-DMAC7.html)
EP (2) EP2258430B1 (cg-RX-API-DMAC7.html)
JP (2) JP5368803B2 (cg-RX-API-DMAC7.html)
KR (1) KR20080091354A (cg-RX-API-DMAC7.html)
CN (4) CN107080746B (cg-RX-API-DMAC7.html)
AU (1) AU2006329678B2 (cg-RX-API-DMAC7.html)
CA (2) CA2826746C (cg-RX-API-DMAC7.html)
ES (2) ES2399288T3 (cg-RX-API-DMAC7.html)
GB (1) GB0526552D0 (cg-RX-API-DMAC7.html)
IL (1) IL192507A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008008616A (cg-RX-API-DMAC7.html)
NO (1) NO20082852L (cg-RX-API-DMAC7.html)
NZ (1) NZ569483A (cg-RX-API-DMAC7.html)
RU (2) RU2445078C2 (cg-RX-API-DMAC7.html)
WO (1) WO2007074344A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0526552D0 (en) 2005-12-29 2006-02-08 Morvus Technology Ltd New use
EP2534957B1 (en) 2007-12-14 2015-05-27 AeroDesigns, Inc Delivering aerosolizable products
AU2009304542A1 (en) * 2008-10-15 2010-04-22 Xingnong Wang Use of tetrose to inhibit cancer and to increase cell viability
US20110216880A1 (en) * 2010-03-05 2011-09-08 General Electric Company System and method for molecular breast imaging
WO2011163671A2 (en) * 2010-06-25 2011-12-29 Boston Polymer Llc Environmentally benign plasticizers based on derivatives of acetone

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208999A (en) 1964-09-09 1965-09-28 Nat Starch Chem Corp Preparation of non-inhibited starch amines
US3658788A (en) * 1969-06-06 1972-04-25 Salk Inst For Biological Studi Aminooxazolines and products thereof and processes for synthesizing same
US3711602A (en) * 1970-10-30 1973-01-16 Crown Zellerbach Corp Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso
JPS52145523A (en) 1976-05-28 1977-12-03 Kouki Yagishita Antiitumor agent
DE2730720C2 (de) 1977-07-07 1979-07-12 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von praktisch reinem l-Amino-8-nitro-43dihydroxy-anthrachinon
CA1089763A (en) 1978-10-30 1980-11-18 Willard J. Johnson Rodenticide comprising 6-aminonicotinamide and 6- aminonicotinohydroxamic acid
CS204501B1 (en) 1978-11-06 1981-04-30 Miroslav Dub Shaped trap for regulation of the numbers of exoantropous and hemisynantropous rodents classes
US4375394A (en) * 1982-03-11 1983-03-01 Eastman Kodak Company Electrolytic process for the preparation of ethylene glycol and glycerine
ATE66375T1 (de) * 1984-10-05 1991-09-15 Bioferon Biochem Substanz Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
GB8804068D0 (en) 1988-02-22 1988-03-23 Roberts J R Improvements relating to control of neoplastic tissue growth
CH680180B5 (cg-RX-API-DMAC7.html) * 1988-07-29 1993-01-15 Ciba Geigy Ag
DE3833194A1 (de) 1988-09-30 1990-04-05 Basf Ag Verfahren zum faerben von textilen materialien aus cellulosefasern
DE4103639A1 (de) * 1991-02-07 1992-08-13 Basf Ag Verfahren zum faerben von textilen materialien aus cellulosefasern
JP4115514B2 (ja) 1991-10-23 2008-07-09 キャンサー・リサーチ・キヤンペーン・テクノロジー・リミテツド Cb 1954およびその類似体を細胞障害性の形態に還元するための細菌のニトロリダクターゼ
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
DE4425436A1 (de) 1994-07-19 1996-01-25 Basf Ag Verfahren zur Herstellung von Acyloinen
GB9415167D0 (en) 1994-07-27 1994-09-14 Springer Caroline J Improvements relating to cancer therapy
US5632782A (en) 1994-09-01 1997-05-27 Clariant Finance (Bvi) Ltd. Exhaust dyeing process for sulphur dyes
US20040053208A1 (en) 1995-08-29 2004-03-18 V. I. TECHNOLOGIES, Inc. Methods to selectively inactivate parasites in biological compositions
WO1997023456A1 (en) 1995-12-21 1997-07-03 British Technology Group Ltd. Indoloquinone derivatives as bioreductive agents
NZ336381A (en) * 1996-12-30 2000-11-24 Battelle Memorial Institute Formulation and method for treating neoplasms by inhalation
JP2001512425A (ja) 1997-02-11 2001-08-21 セラマーク・リミテッド 薬物ターゲティング
GB9710699D0 (en) 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
GB9712370D0 (en) 1997-06-14 1997-08-13 Aepact Ltd Therapeutic systems
GB2365338B (en) 1997-06-14 2002-04-03 Enzacta R & D Ltd Therapeutic systems
US6159706A (en) 1997-12-23 2000-12-12 Newbiotics, Inc. Application of enzyme prodrugs as anti-infective agents
JP2002516304A (ja) 1998-05-22 2002-06-04 シオノギ・バイオリサーチ・コーポレーション 生体還元性細胞傷害剤
JP2002523382A (ja) 1998-08-19 2002-07-30 ザ・ビクトリア・ユニバーシテイ・オブ・マンチエスター 薬物ターゲティング
HK1049443A1 (zh) * 1999-11-12 2003-05-16 Angiotech Pharmaceuticals, Inc. 用放射活性疗法和细胞循环抑制剂联合治疗疾病的组合物和方法
AU783128B2 (en) 2000-03-02 2005-09-29 Innovata Plc TCF responsive element
CN1437594A (zh) * 2000-06-22 2003-08-20 辉瑞产品公司 用于治疗异常细胞生长的取代的双环衍生物
DE10049468A1 (de) 2000-10-06 2002-04-11 Bayer Ag N-Alkoxyalkyl-substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
DK1355566T3 (da) * 2000-12-18 2013-03-04 Univ Texas Lokal regional kemoterapi og radioterapi ved anvendelse af hydrogel in situ
US20030228285A1 (en) 2002-05-03 2003-12-11 Mien-Chie Hung Bipartite T-cell factor (Tcf)-responsive promoter
GB0223696D0 (en) 2002-10-14 2002-11-20 Ml Lab Plc Improved immunotherapy
GB0313604D0 (en) * 2003-06-12 2003-07-16 Britannia Pharmaceuticals Ltd Delivery device for powdered medicament
DE102004009434A1 (de) * 2004-02-24 2005-12-15 Boehringer Ingelheim International Gmbh Zerstäuber
FR2871697B1 (fr) 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
CA2570245A1 (en) 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions and methods for treating pathological infections
GB0517957D0 (en) 2005-09-03 2005-10-12 Morvus Technology Ltd Method of combating infection
GB0526552D0 (en) 2005-12-29 2006-02-08 Morvus Technology Ltd New use

Similar Documents

Publication Publication Date Title
ES2715926T3 (es) Compuestos para el tratamiento del cáncer
JP2008511601A5 (cg-RX-API-DMAC7.html)
CA2055859A1 (fr) Derives d'oxazolopyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JP2011524422A5 (cg-RX-API-DMAC7.html)
JP2001517699A5 (cg-RX-API-DMAC7.html)
JP2005519083A5 (cg-RX-API-DMAC7.html)
JP2011504903A5 (cg-RX-API-DMAC7.html)
JP2009535307A5 (cg-RX-API-DMAC7.html)
US20160184265A1 (en) Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
JP2003506354A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
JP2009524675A5 (cg-RX-API-DMAC7.html)
MX2009000283A (es) Compuestos quimicos.
CN113966324B (zh) Notch信号传导途径抑制剂及其在癌症治疗的用途
TW201036988A (en) Phosphothiophene and phosphothiazole HCV polymerase inhibitors
JP2022521081A (ja) Hbv感染若しくはhbv誘導性疾患の治療において有用なアミド誘導体
US20240287048A1 (en) Substituted acyl sulfonamides for treating cancer
JP2025509846A5 (cg-RX-API-DMAC7.html)
US9079876B2 (en) Imidazole derivatives and preparation method and use thereof
JP2007532625A5 (cg-RX-API-DMAC7.html)
RU2008131054A (ru) Применение альфа-гидроксикарбонильных соединений в качестве восстанавливающих веществ
KR20140141904A (ko) 신규한 항암활성을 갖는 사마필린a 유도체 및 이를 함유하는 약학적 조성물
WO1998043943A1 (fr) Derives de 2-phenoxyaniline
JP2017516824A5 (cg-RX-API-DMAC7.html)
JP2004528293A5 (cg-RX-API-DMAC7.html)